 | • レポートコード：MRC2312MG14690 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、79ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のアジュバント使用インフルエンザワクチン市場規模と予測を収録しています。・世界のアジュバント使用インフルエンザワクチン市場：売上、2018年-2023年、2024年-2029年 ・世界のアジュバント使用インフルエンザワクチン市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のアジュバント使用インフルエンザワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「バイアル」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 アジュバント使用インフルエンザワクチンのグローバル主要企業は、CSLなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、アジュバント使用インフルエンザワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のアジュバント使用インフルエンザワクチン市場：タイプ別、2018年-2023年、2024年-2029年 世界のアジュバント使用インフルエンザワクチン市場：タイプ別市場シェア、2022年 ・バイアル、充填済み 世界のアジュバント使用インフルエンザワクチン市場：用途別、2018年-2023年、2024年-2029年 世界のアジュバント使用インフルエンザワクチン市場：用途別市場シェア、2022年 ・公共、民間 世界のアジュバント使用インフルエンザワクチン市場：地域・国別、2018年-2023年、2024年-2029年 世界のアジュバント使用インフルエンザワクチン市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるアジュバント使用インフルエンザワクチンのグローバル売上、2018年-2023年 ・主要企業におけるアジュバント使用インフルエンザワクチンのグローバル売上シェア、2022年 ・主要企業におけるアジュバント使用インフルエンザワクチンのグローバル販売量、2018年-2023年 ・主要企業におけるアジュバント使用インフルエンザワクチンのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 CSL ************************************************************* ・調査・分析レポートの概要 アジュバント使用インフルエンザワクチン市場の定義 市場セグメント 世界のアジュバント使用インフルエンザワクチン市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のアジュバント使用インフルエンザワクチン市場規模 世界のアジュバント使用インフルエンザワクチン市場規模：2022年 VS 2029年 世界のアジュバント使用インフルエンザワクチン市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのアジュバント使用インフルエンザワクチンの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のアジュバント使用インフルエンザワクチン製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：バイアル、充填済み アジュバント使用インフルエンザワクチンのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：公共、民間 アジュバント使用インフルエンザワクチンの用途別グローバル売上・予測 ・地域別市場分析 地域別アジュバント使用インフルエンザワクチン市場規模 2022年と2029年 地域別アジュバント使用インフルエンザワクチン売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） CSL ... |
This research report provides a comprehensive analysis of the Adjuvanted Influenza Vaccine market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Adjuvanted Influenza Vaccine market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Adjuvanted Influenza Vaccine, challenges faced by the industry, and potential opportunities for market players.
The global Adjuvanted Influenza Vaccine market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Adjuvanted Influenza Vaccine market presents opportunities for various stakeholders, including Public Sector, Private Sector. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Adjuvanted Influenza Vaccine market. Additionally, the growing consumer demand present avenues for market expansion.
The global Adjuvanted Influenza Vaccine market was valued at US$ 898.2 million in 2022 and is projected to reach US$ 2128.8 million by 2029, at a CAGR of 12.8% during the forecast period.
A significant driver in the Influenza Vaccine market is the growing awareness of the importance of vaccination in preventing seasonal and pandemic influenza outbreaks. As healthcare organizations and governments worldwide promote vaccination as a crucial public health measure, there is an increasing demand for influenza vaccines. Additionally, advances in vaccine research and development, including the production of more effective and broader-spectrum vaccines, are driving market growth. One of the key challenges in this market is the need for frequent vaccine updates to match evolving influenza strains. The virus undergoes genetic changes, requiring annual adjustments to vaccine formulations. This presents logistical challenges for manufacturers in terms of timely production and distribution. Vaccine hesitancy and misinformation also pose challenges by impacting vaccination rates and public perception. Lastly, ensuring equitable access to vaccines, especially in low-income and underserved populations, remains a persistent challenge in the fight against influenza.
Key Features:
The research report on the Adjuvanted Influenza Vaccine market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Adjuvanted Influenza Vaccine market.
Market Overview: The report provides a comprehensive overview of the Adjuvanted Influenza Vaccine market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Vial, Prefilled), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Adjuvanted Influenza Vaccine market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Adjuvanted Influenza Vaccine market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Adjuvanted Influenza Vaccine market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Adjuvanted Influenza Vaccine market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Adjuvanted Influenza Vaccine market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Adjuvanted Influenza Vaccine market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Adjuvanted Influenza Vaccine, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Adjuvanted Influenza Vaccine market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Adjuvanted Influenza Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Vial
Prefilled
Market segment by Application
Public Sector
Private Sector
Global Adjuvanted Influenza Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
CSL
Outline of Major Chapters:
Chapter 1: Introduces the definition of Adjuvanted Influenza Vaccine, market overview.
Chapter 2: Global Adjuvanted Influenza Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Adjuvanted Influenza Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Adjuvanted Influenza Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Adjuvanted Influenza Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Adjuvanted Influenza Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Adjuvanted Influenza Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Adjuvanted Influenza Vaccine Overall Market Size
2.1 Global Adjuvanted Influenza Vaccine Market Size: 2022 VS 2029
2.2 Global Adjuvanted Influenza Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Adjuvanted Influenza Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Adjuvanted Influenza Vaccine Players in Global Market
3.2 Top Global Adjuvanted Influenza Vaccine Companies Ranked by Revenue
3.3 Global Adjuvanted Influenza Vaccine Revenue by Companies
3.4 Global Adjuvanted Influenza Vaccine Sales by Companies
3.5 Global Adjuvanted Influenza Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Adjuvanted Influenza Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Adjuvanted Influenza Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Adjuvanted Influenza Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Adjuvanted Influenza Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Adjuvanted Influenza Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Adjuvanted Influenza Vaccine Market Size Markets, 2022 & 2029
4.1.2 Vial
4.1.3 Prefilled
4.2 By Type – Global Adjuvanted Influenza Vaccine Revenue & Forecasts
4.2.1 By Type – Global Adjuvanted Influenza Vaccine Revenue, 2018-2023
4.2.2 By Type – Global Adjuvanted Influenza Vaccine Revenue, 2024-2029
4.2.3 By Type – Global Adjuvanted Influenza Vaccine Revenue Market Share, 2018-2029
4.3 By Type – Global Adjuvanted Influenza Vaccine Sales & Forecasts
4.3.1 By Type – Global Adjuvanted Influenza Vaccine Sales, 2018-2023
4.3.2 By Type – Global Adjuvanted Influenza Vaccine Sales, 2024-2029
4.3.3 By Type – Global Adjuvanted Influenza Vaccine Sales Market Share, 2018-2029
4.4 By Type – Global Adjuvanted Influenza Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Adjuvanted Influenza Vaccine Market Size, 2022 & 2029
5.1.2 Public Sector
5.1.3 Private Sector
5.2 By Application – Global Adjuvanted Influenza Vaccine Revenue & Forecasts
5.2.1 By Application – Global Adjuvanted Influenza Vaccine Revenue, 2018-2023
5.2.2 By Application – Global Adjuvanted Influenza Vaccine Revenue, 2024-2029
5.2.3 By Application – Global Adjuvanted Influenza Vaccine Revenue Market Share, 2018-2029
5.3 By Application – Global Adjuvanted Influenza Vaccine Sales & Forecasts
5.3.1 By Application – Global Adjuvanted Influenza Vaccine Sales, 2018-2023
5.3.2 By Application – Global Adjuvanted Influenza Vaccine Sales, 2024-2029
5.3.3 By Application – Global Adjuvanted Influenza Vaccine Sales Market Share, 2018-2029
5.4 By Application – Global Adjuvanted Influenza Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Adjuvanted Influenza Vaccine Market Size, 2022 & 2029
6.2 By Region – Global Adjuvanted Influenza Vaccine Revenue & Forecasts
6.2.1 By Region – Global Adjuvanted Influenza Vaccine Revenue, 2018-2023
6.2.2 By Region – Global Adjuvanted Influenza Vaccine Revenue, 2024-2029
6.2.3 By Region – Global Adjuvanted Influenza Vaccine Revenue Market Share, 2018-2029
6.3 By Region – Global Adjuvanted Influenza Vaccine Sales & Forecasts
6.3.1 By Region – Global Adjuvanted Influenza Vaccine Sales, 2018-2023
6.3.2 By Region – Global Adjuvanted Influenza Vaccine Sales, 2024-2029
6.3.3 By Region – Global Adjuvanted Influenza Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Adjuvanted Influenza Vaccine Revenue, 2018-2029
6.4.2 By Country – North America Adjuvanted Influenza Vaccine Sales, 2018-2029
6.4.3 US Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.4.4 Canada Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.4.5 Mexico Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Adjuvanted Influenza Vaccine Revenue, 2018-2029
6.5.2 By Country – Europe Adjuvanted Influenza Vaccine Sales, 2018-2029
6.5.3 Germany Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.5.4 France Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.5.5 U.K. Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.5.6 Italy Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.5.7 Russia Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.5.9 Benelux Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Adjuvanted Influenza Vaccine Revenue, 2018-2029
6.6.2 By Region – Asia Adjuvanted Influenza Vaccine Sales, 2018-2029
6.6.3 China Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.6.4 Japan Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.6.5 South Korea Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.6.7 India Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Adjuvanted Influenza Vaccine Revenue, 2018-2029
6.7.2 By Country – South America Adjuvanted Influenza Vaccine Sales, 2018-2029
6.7.3 Brazil Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.7.4 Argentina Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Adjuvanted Influenza Vaccine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Adjuvanted Influenza Vaccine Sales, 2018-2029
6.8.3 Turkey Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.8.4 Israel Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Adjuvanted Influenza Vaccine Market Size, 2018-2029
6.8.6 UAE Adjuvanted Influenza Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 CSL
7.1.1 CSL Company Summary
7.1.2 CSL Business Overview
7.1.3 CSL Adjuvanted Influenza Vaccine Major Product Offerings
7.1.4 CSL Adjuvanted Influenza Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 CSL Key News & Latest Developments
8 Global Adjuvanted Influenza Vaccine Production Capacity, Analysis
8.1 Global Adjuvanted Influenza Vaccine Production Capacity, 2018-2029
8.2 Adjuvanted Influenza Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Adjuvanted Influenza Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Adjuvanted Influenza Vaccine Supply Chain Analysis
10.1 Adjuvanted Influenza Vaccine Industry Value Chain
10.2 Adjuvanted Influenza Vaccine Upstream Market
10.3 Adjuvanted Influenza Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Adjuvanted Influenza Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
